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as in most other diseases, are so highly
orientated, the availability of a text which
traverses the boundaries of the various
disciplines is to be welcomed. The volume has
the additional advantage of extensive biblio-
graphies after each article. It is thus an
excellent work of reference, as well as an up-
to-date account of the status of breast cancer
research.
M. MOORE
Opportunistic Infection in Cancer
Patients. J. AUBERTIN, B. HOERNI, J. Y.
LACUT & M. DURAND (1978). U.S.A.:
Masson Publishing. 197 Pp. £15.80.
With advances in cancer treatments, par-
ticularly cytotoxic combinations, the prog-
nosis in several tumours has improved con-
siderably over the past decade. Not un-
expectedly, this has in some instances led to
increased toxicity, particularly in opportunis-
tic infections. These are readily amenable to
appropriate treatment, and can be resolved
satisfactorily if the clinician is alert to the
problem and instigates the correct therapy.
This book therefore comes at an opportune
time and presents an up-to-date review of
important aspects in the management of
infection in the patient with cancer.
The first section deals with general topics,
in particular those factors that predispose to
infection, and adequate coverage is given to
aetiology and problems concerned with
diagnosis. The second section deals with
clinical and diagnostic aspects, and detailed
coverage is given to the important opportun-
istic infections due to fungi-and parasites. The
final section is devoted to treatment, and
adequate discussion is given here to current
antibiotic policy. I think, however, that it
would have given added credence to the book
ifmore space had been devoted to supportive
care. It is, however, a book that is to be
recommended to all those concerned in the
clinical management of cancer patients. At
£15.80 it is probably beyond the reach of
junior staff, but should be present in all
relevant libraries.
P. M. WILKINSON
Endometrial Cancer. Eds. M. G. BRUSH,
R. J. B. KING & R. W. TAYLOR (1978).
London: Bailliere Tindall. 459 pp. £16.50.
This is not a text book, but the collected
papers presented at the Second International
Conference on Endometrial Cancer in May
1977. Forty-five papers gathered into 8
sections are republished without any of the
attendant discussions or editorial summaries
that one might have expected. The papers
range from general reviews to individual
scientific studies of widely varying size and
complexity. The general introductions and
discussions within the papers contain an
extensive amount of overlapping information
which, while complete within the context of
the paper, is tedious if papers are read
sequentially. The 8 sections cover the whole
range ofthe relatively neglected field ofendo-
metrial carcinoma, with those on epidemi-
ology, long-term oestrogen therapy, clinical
treatment and experimental endocrinology
occupying the bulk of the book.
Looking at the individual papers, in the
first section there is an excellent review
by Mack of the validity of the different
arguments surrounding oestrogen therapy
and the possible changing incidence of the
disease.
The second section, on the relationship of
oestrogens and carcinoma, opens with a
balanced review ofthe problem by Lauritzen.
His rules for long-term oestrogen therapy are
impressive for their simplicity and common
sense. The section then strays away from
malignant disease to good papers by Sturdee
and Whitehead, detailing the uterine mucosal
response to different oestrogen therapies. The
unpredictability ofthis response and the need
for sequential analysis of endometrial tissue
emerges clearly.
Ober's Recent Ideas on the Pathology of
Endometrial Carcinoma opens the pathology
section. The clarity of style produces an
authoritative view ofthis difficult field, which
must not be missed by any clinically orien-
tated reader.
The long section on Clinical Treatment in-
cludes papers discussing the extent ofprimary
surgery, the relative values of pre- and post-
operative radiotherapy, adjuvant progesto-
gens in early disease and progestogens in late
and recurrent disease. All the results pre-
sented come from clinical studies which seek
to answer questions that can only be
answered by randomized clinical trials. The
points of view are well presented and
cogently argued, but their long-term value is
very limited. In later papers Kohorn does